Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Lisa K. Hicks, Inna Y. Gong et al.|Blood|2020Cited by 657
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicityToby A. Eyre, Chris S.R Hatton, Stephen Booth et al.|British Journal of Haematology|2019Cited by 65
Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in EnglandHannah Higgins, Beverley J. Hunt, Nick Andrews et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 10
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancerFarasat Kazmi, Sarah P. Blagden, Nipun Shrestha et al.|Cochrane Database of Systematic Reviews|2025Cited by 5
Next-generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancerFarasat Kazmi, Sarah P. Blagden, Stephen Booth et al.|Cochrane Database of Systematic Reviews|2021Cited by 2